MedTrace Logo

Effects of Intrauterine Flushing With Human Chorionic Gonadotropin on ICSI Outcome

NCT06684951 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2025-09-19

Study results available
· View outcomes & findings →

Summary

a number of infertile women who were prepared for ICSI and immediately post ova pick up intrauterine flushing with human chorionic gonadotropin was done to study the effect of this drug on ICSI outcome and ultrasound parameter.

Conditions

  • Female Infertility

Interventions

DRUG

hCG

observe hCG effect on endometrial receptivity

Sponsors & Collaborators

  • Omayma Ismail Khalaf

    lead OTHER

Principal Investigators

  • Manal T Al-Obaidi, phD. · High Institute for Infertility Diagnosis and Reproductive Technique

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-23
Primary Completion
2024-01-23
Completion
2024-04-30
FDA Drug
Yes

Countries

  • Iraq

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06684951 on ClinicalTrials.gov